Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Eagle Pharmaceuticals

Explore full profile

A specialty pharmaceutical company focused on developing and commercializing injectable products

Woodcliff Lake, United StatesFounded 2007Biotech & Life Sciences
Valuation $4.9M Market cap · Aug/2026
Revenue $373M Latest reported FY
EBITDA $65M Latest reported FY

At a glance

Status
Listed
Founded
2007
Headquarters
Woodcliff Lake, United States
Listing
IPO 2014
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States94.4%
🇪🇬 Egypt3%
🇮🇳 India1.3%
🇰🇪 Kenya1.3%
4 countries shown
Web traffic by country
3.6K monthly visits
across markets
🇺🇸 United States69.4%
🇮🇳 India30.6%
Top 2 markets shown

Patents

Estimated portfolio value
$146M

46 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Eagle Pharmaceuticals was the backer or acquirer, 2016–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Eagle Pharmaceuticals's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Eagle Pharmaceuticals deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Eagle Pharmaceuticals's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Eagle Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Eagle Pharmaceuticals on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles